First Total Synthesis of (+)-11,11′-Dideoxyverticillin A
Posted by SR in News, tags: natural product, oncology, total synthesis
Although it is ten years since the anti-cancer properties of (+)-11,11′-dideoxyverticillin A were first described, it is only now that the first total synthesis has been reported. The compound was originally isolated from the mycelium of a marine-derived fungus of the genus Penicillium and has since been found in several other fungal species including Shiraia bambusicola, a parasitic fungus which grows on some species of bamboo.
With ten rings and eight stereogenic centres, (+)-11,11′-dideoxyverticillin A is one of the most complex of a family of dimeric epidithiodiketopiperazine natural products. Writing in the journal Science, chemists at the Massachusetts Institute of Technology have now described an enantioselective 11-step synthesis, starting from the commercially available amino acids, tryptophan and alanine. The synthesis was designed to mimic a plausible biosynthetic pathway and, as well as providing ready access to (+)-11,11′-dideoxyverticillin A itself, should provide access to analogues which may have enhanced pharmacological activity. The elegant synthesis used a minimum of protecting groups and, by taking full advantage of the inherent reactivity of intermediates, offers insights into the natural biosynthetic pathways. (+)-11,11′-Dideoxyverticillin A inhibits the tyrosine kinase activity of the epidermal growth factor receptor with an IC50 of 0.14nM, shows anti-angiogenic activity, and prevents the growth of several cancer cell lines.
Related posts:
- Modified Plant Extract Could Rival Viagra Plant extracts have traditionally been used as aphrodisiacs and a recent report describes the synthesis of a modified natural product...
- Targeting Artemisinin to Cancer Cells Sweet Wormwood (Artemisia annua L) has been used since ancient times in Chinese herbal medicine to treat fever. More recently,...
- Phase III Study for Oxidative Stress Inducer, Elesclomol Synta Pharmaceuticals has recently announced enrolment of 630 patients for a pivotal Phase III trial of elesclomol (STA-4783) in patients...
- PARP Inhibitors – More Widely Effective than First Thought The PARP (poly (ADP-ribose) polymerase) family of nuclear enzymes play key roles in a variety of cellular processes, including DNA...
- MAGL Contributes to Aggressiveness in Cancer Despite a growing understanding that the conversion of normal cells into cancerous cells is accompanied by metabolic changes, it remains...
Related posts brought to you by Yet Another Related Posts Plugin.
This entry was posted on Tuesday, May 5th, 2009 at 8:53 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
















Entries (RSS)